Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:03 PM ET 8-K
Financial Results Curaleaf Holdings, Inc. CURLF

Curaleaf Holdings Financial Results

Curaleaf Holdings reported record third-quarter 2026 revenue of $352.7 million, a 10.9% year-over-year increase driven by strong domestic and international growth. Despite the revenue record, the company reported a net loss from continuing operations of $37.4 million for the quarter, while maintaining an adjusted EBITDA margin of 22%.

Term
Q3 2026

“We are building the global leader in cannabis, and our third-quarter results provide further evidence that our strategy is delivering. Solid execution across the business is driving growth, strengthening our competitive position, and advancing our Built for Growth plan.”

Boris Jordan, Chairman and CEO

“These results reflect the disciplined execution of our entire team and reinforce the strength of our global platform. We are translating operational improvements into stronger financial performance, building momentum across the business, and positioning Curaleaf for sustained growth and greater cash generation.”

Boris Jordan, Chairman and CEO
4:03 PM ET 8-K
Investor Presentation Axos Financial, Inc. AX

Axos Financial Investor Presentation

Axos Financial, Inc. filed a formal investor presentation deck (Exhibit 99.1) to be used in meetings with investors and analysts beginning November 4, 2026. The presentation outlines the company's investment thesis across its consumer banking, commercial banking, and securities divisions, highlighting its structural cost advantages and diversified growth strategy.

4:03 PM ET 10-Q
Financial Results Sixth Street Specialty Lending, Inc. TSLX

Sixth Street Specialty Lending Q3 2026 Results: Net Income $34.4M, Down 22.8% YoY

For the nine months ended September 30, 2026, Sixth Street Specialty Lending reported total investment income of $290.2 million and net investment income of $122.3 million, down from $159.5 million in the prior year period. Net asset value per share decreased to $16.19 from $16.98 at year-end 2025, primarily driven by net realized and unrealized losses totaling $73.4 million.

Key figure
Net income $34.4M · -22.8% YoY
4:03 PM ET Form 4
Insider Selling Generac Holdings Inc. GNRC

Generac Holdings CEO Aaron Jagdfeld Sells $1M of Stock

Aaron Jagdfeld, CEO, sold 5,000 shares of Generac Holdings Inc. at $200.61 a share, worth $1M in total on Nov 2, 2026. Shares held after the trade: 539,528 (-0.9%).

Value
$1M
Shares
5,000
Price
$200.61
Role
CEO
Holding change
-0.9%
Trade date
Nov 2, 2026
4:03 PM ET Form 4
Insider Selling Paylocity Holding Corp PCTY

Paylocity Holding Insider Steven I. Sarowitz Sells $1.09M of Stock

Steven I. Sarowitz sold 6,374 shares of Paylocity Holding Corp at $170.22 to $172.36 a share (average $171.10) in 3 transactions, worth $1.09M in total on Oct 30, 2026. Shares held after the trade: 4,348,395 (-0.0%).

Value
$1.09M
Shares
6,374
Average price
$171.10
Holding change
-0.0%
Trade date
Oct 30, 2026
4:03 PM ET Form 4
Insider Selling Regeneron Pharmaceuticals, Inc. REGN

Regeneron Pharmaceuticals EVP Commercial Marion McCourt Sells $984K of Stock

Marion McCourt, EVP Commercial, sold 1,132 shares of Regeneron Pharmaceuticals, Inc. at $869.43 a share, worth $984K in total on Oct 30, 2026. Shares held after the trade: 10,871 (-9.4%).

Value
$984K
Shares
1,132
Price
$869.43
Role
EVP Commercial
Holding change
-9.4%
Trade date
Oct 30, 2026
4:03 PM ET 8-K
Financial Results Gladstone Commercial Corp GOOD

Gladstone Commercial Financial Results

Gladstone Commercial Corporation reported financial results for the third quarter ended September 30, 2026, including total operating revenue of $42.4 million. The company reported a net loss available to common stockholders of $5.2 million, or $0.11 per share, primarily impacted by a $6.5 million impairment charge. Core FFO for the quarter was $16.9 million, or $0.35 per diluted share.

Term
Q3 2026
4:03 PM ET 8-K
Financial Results Manitowoc Co Inc MTW

Manitowoc Co Financial Results

Manitowoc reported strong third-quarter 2026 results with net sales of $613.8 million, up 10.9% year-over-year, and a 37.6% surge in orders to $676.4 million. Driven by robust crane demand in the Americas and Middle East, the company raised its full-year 2026 adjusted EBITDA and adjusted EPS guidance.

Term
Q3 2026

“Manitowoc’s third quarter results exceeded our expectations, highlighted by robust orders, double-digit sales growth, and a significant improvement in adjusted EBITDA. Backlog expanded over the last four consecutive quarters, reflecting continued strength in crane demand, particularly in the Americas, Middle East, and Asia Pacific, providing good visibility to the fourth quarter and into 2027.”

Aaron H. Ravenscroft, President and Chief Executive Officer

“For the remainder of the year, our priorities remain clear: execute against our backlog, improve working-capital efficiency, and continue to grow the aftermarket business through our CRANES+50 strategy. Given our strong momentum, we have raised our guidance for adjusted EBITDA and adjusted diluted earnings per share.”

Aaron H. Ravenscroft, President and Chief Executive Officer
4:02 PM ET 8-K
Financial Results Spyre Therapeutics, Inc. SYRE

Spyre Therapeutics Financial Results

Spyre Therapeutics reported third quarter 2026 financial results, highlighting a pro forma cash position of $1.5 billion following a $400 million public offering in October. The company achieved clinical proof-of-concept for its three IBD monotherapies and is advancing combination trials with data expected in Q3 2027.

Term
Q3 2026

“We are increasingly well-positioned to deliver on our ambition of elevating the standard of care across immunology. In IBD, our three compelling Phase 2 monotherapy readouts and a growing body of supportive clinical evidence strengthen our conviction that our combination products have the potential to transform the treatment paradigm.”

Cameron Turtle, DPhil, Chief Executive Officer of Spyre
4:02 PM ET 10-Q
Financial Results Douglas Dynamics, Inc PLOW

Douglas Dynamics Q3 2026 Results: Net Income $21.2M, Up 165.8% YoY

Douglas Dynamics reported a significant increase in net sales to $218.0 million for the third quarter of 2026, up from $162.1 million in the prior year. Net income for the nine months ended September 30, 2026, rose to $52.9 million compared to $34.1 million in 2025, driven by higher gross profits and improved operational performance.

Key figure
Net income $21.2M · +165.8% YoY
4:02 PM ET 10-Q
Financial Results TPG Inc. TPG

TPG Q3 2026 Results: Net Income $99.6M, Up 48.4% YoY

TPG Inc. filed its 10-Q for the quarter ended September 30, 2026, reporting 167,443,419 shares of Class A common stock outstanding as of October 30, 2026. The filing includes unaudited condensed consolidated financial statements and details regarding the company's reorganization and acquisitions, such as Angelo Gordon and Peppertree.

Key figure
Net income $99.6M · +48.4% YoY
4:02 PM ET 10-Q
Financial Results Bowhead Specialty Holdings Inc. BOW

Bowhead Specialty Holdings Q3 2026 Results: Net Income $12.9M, Down 14.7% YoY

Bowhead Specialty Holdings Inc. reported net income of $45.1 million for the nine months ended September 30, 2026, compared to $38.9 million in the prior year period. Gross written premiums grew 20.7% year-over-year to $771.1 million, though the company experienced a significant unrealized loss on investments of $49.7 million during the period.

Key figure
Net income $12.9M · -14.7% YoY
4:02 PM ET 8-K
Deal Termination Nurix Therapeutics, Inc. NRIX

Nurix Therapeutics Deal Termination with Sanofi S.A.

Nurix Therapeutics announced that its collaboration partner Sanofi has decided to discontinue the Phase 1 clinical trial and terminate the SAR448272 oral STAT6 degrader program. As a result, Nurix will no longer be eligible for future development, regulatory, or commercial milestone payments and royalties specifically for this program, though other licensed programs under the Sanofi collaboration remain active.

Counterparty
Sanofi S.A.
4:02 PM ET Form 4
Insider Selling Kforce Inc KFRC

Kforce Insider David L. Dunkel Sells $293K of Stock

David L. Dunkel sold 5,000 shares of Kforce Inc at $58.06 to $59.50 a share (average $58.67) in 4 transactions, worth $293K in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 506,329 (-0.3%).

Value
$293K
Shares
5,000
Average price
$58.67
Holding change
-0.3%
Trade date
Oct 30, 2026 to Nov 2, 2026
4:02 PM ET 10-Q
Financial Results Monolithic Power Systems, Inc. MPWR

Monolithic Power Systems Q3 2026 Results: Net Income $271M, Up 50.8% YoY

Monolithic Power Systems reported significant growth for the quarter ended September 30, 2026, with revenue increasing to $1.20 billion from $737.2 million in the prior year. Net income rose to $271.1 million, or $5.51 per diluted share, while the company significantly increased its common stock repurchases to $457.5 million for the first nine months of the year.

Key figure
Net income $271M · +50.8% YoY
4:02 PM ET 10-Q
Financial Results Zebra Technologies Corp ZBRA ▶ Call

Zebra Technologies Q3 2026 Results: Net Income $164M, Up 62.4% YoY

Zebra Technologies reported a significant increase in net sales to $1,614 million for the quarter ended October 3, 2026, compared to $1,320 million in the prior year. Net income rose to $164 million from $101 million, driven by strong growth in tangible product sales and improved operating margins.

Key figure
Net income $164M · +62.4% YoY
4:02 PM ET Form 4
Insider Selling Interface Inc TILE

Interface Director Daniel T. Hendrix Sells $313K of Stock

Daniel T. Hendrix, Director, sold 8,196 shares of Interface Inc at $38.13 a share, worth $313K in total on Nov 2, 2026. Shares held after the trade: 71,951 (-10.2%).

Value
$313K
Shares
8,196
Price
$38.13
Role
Director
Holding change
-10.2%
Trade date
Nov 2, 2026
4:02 PM ET Form 4
Insider Selling Brunswick Corp BC

Brunswick Insider Nancy E. Cooper Sells $16.5K of Stock

Nancy E. Cooper sold 216 shares of Brunswick Corp at $76.23 a share, worth $16.5K in total on Nov 2, 2026. Shares held after the trade: 28,586 (-0.7%).

Value
$16.5K
Shares
216
Price
$76.23
Holding change
-0.7%
Trade date
Nov 2, 2026
4:02 PM ET 8-K
Financial Results Flywire Corp FLYW

Flywire Financial Results

Flywire reported Q3 2026 revenue of $250.3 million, a 25.1% year-over-year increase, driven by strong performance in its education vertical and strategic enterprise wins. The company raised its full-year 2026 guidance for FX-neutral revenue growth and Adjusted EBITDA margin, citing disciplined execution and record free cash flow.

Term
Q3 2026

“Q3 showed the sustainability of our growth. Through our seasonal education peak, we delivered strong top-line growth with disciplined execution across all four verticals. The financial profile reflects it: expanding adjusted EBITDA margins, and more profit and free cash flow than at any point in our history. That gives us real choices, and the best returns we see today are in our own business: deepening our competitive moat, gaining share and solving complex, high-friction financial workflows around the world”

Mike Massaro, Flywire’s CEO
4:02 PM ET 10-Q
Financial Results Archer-Daniels-Midland Co ADM ▶ Call

Archer-Daniels-Midland Q3 2026 Results: Net Income $821M, Up 660.2% YoY

Archer-Daniels-Midland reported a significant increase in net earnings for the third quarter of 2026, reaching $821 million compared to $108 million in the prior year period. This growth was driven by higher revenues of $22.3 billion and a substantial reduction in asset impairment and restructuring costs.

Key figure
Net income $821M · +660.2% YoY
4:02 PM ET 8-K
Financial Results Ramaco Resources, Inc. METC

Ramaco Resources Financial Results

Ramaco Resources reported a third-quarter net loss of $18.2 million and Adjusted EBITDA of $3.0 million. The company highlighted strong liquidity of $375 million and announced it has secured 1.7 million tons of domestic business for 2027 at an average price of $139 per ton.

Term
Q3 2026
4:02 PM ET 8-K
Financial Results Red Rock Resorts, Inc. RRR

Red Rock Resorts Financial Results

Red Rock Resorts reported third quarter 2026 net revenues of $488.7 million, a 2.8% increase year-over-year. The company swung to a net loss of $17.7 million, primarily due to $79.1 million in share-based compensation and $6.9 million in one-time expenses related to its 50th anniversary employee stock awards.

Term
Q3 2026
4:02 PM ET 8-K
Shareholder Meeting Mercury Systems Inc MRCY

Mercury Systems Shareholder Meeting

Mercury Systems held its 2026 Annual Meeting of Shareholders on October 28, 2026, where shareholders elected Jean Bua, Gerard J. DeMuro, and Scott Ostfeld as Class II Directors. Shareholders also approved executive compensation on an advisory basis and ratified KPMG LLP as the independent auditor for fiscal 2027.

4:02 PM ET 8-K
Financial Results Crexendo, Inc. CXDO

Crexendo Financial Results

Crexendo, Inc. reported third quarter 2026 financial results with total revenue increasing 44% year-over-year to $25.2 million. The company achieved GAAP net income of $1.1 million and Adjusted EBITDA of $4.0 million, driven by a 75% increase in service revenue.

Term
Q3 2026
4:02 PM ET 8-K
Divestiture Salamander Innisbrook, LLC

Salamander Innisbrook Divestiture to Concert Innisbrook, LLC and CGP Innisbrook, LLC for $19.8M

Salamander Innisbrook, LLC entered into a definitive agreement to sell the Innisbrook Resort and Golf Club, along with three condominium units, to Concert Innisbrook, LLC and CGP Innisbrook, LLC for $19.8 million in cash. The company expects to use the proceeds to repay its outstanding Truist Bank loan in full, with the transaction expected to close by December 31, 2026.

Value
$19.8M
Counterparty
Concert Innisbrook, LLC and CGP Innisbrook, LLC
4:02 PM ET 10-Q
Financial Results Ssr Mining Inc. SSRM ▶ Call

Ssr Mining Q3 2026 Results: Net Income $79.9M, Up 22.1% YoY

SSR Mining Inc. reported a significant increase in revenue to $1.47 billion for the nine months ended September 30, 2026, compared to $1.11 billion in the prior year. The company recorded a substantial net loss from discontinued operations of $425.4 million, primarily related to the divestiture of the Çöpler mine, which provided $1.50 billion in cash proceeds.

Key figure
Net income $79.9M · +22.1% YoY
4:02 PM ET 8-K
Leadership Change Astec Industries Inc ASTE

Astec Industries Leadership Change

Astec Industries announced a board transition involving the resignation of director Linda Knoll, effective December 14, 2026, and the appointment of John Keating as an independent director, effective December 11, 2026. Mr. Keating, a former executive at CRH plc with over 40 years of industry experience, will also serve on the Audit Committee.

4:01 PM ET 8-K
Financial Results AtriCure, Inc. ATRC

AtriCure Financial Results

AtriCure reported third quarter 2026 worldwide revenue of $154.5 million, a 15% year-over-year increase driven by strong U.S. sales in post-operative pain management and appendage management. The company achieved profitability expansion with net income of $4.1 million and adjusted EBITDA of $26.8 million, while raising its full-year 2026 revenue guidance to a range of $606 million to $610 million.

Term
Q3 2026

“Our third quarter results demonstrate the strength of our broad portfolio and our team’s disciplined execution. Adoption of our innovative technologies is driving strong growth and expanding profitability, while the rapid progress of our BoxX-NoAF clinical trial reinforces our confidence in the opportunities ahead.”

Michael Carrel, President and Chief Executive Officer
4:01 PM ET 10-Q
Financial Results Spyre Therapeutics, Inc. SYRE

Spyre Therapeutics Q3 2026 Results: Net Loss of $96.1M, Loss Widens

Spyre Therapeutics reported a significant increase in its financial position, with total current assets growing from $777.8 million at the end of 2025 to approximately $1.1 billion as of September 30, 2026, primarily driven by an increase in marketable securities. The company is advancing its clinical pipeline, including the SKYLINE and SKYLIGHT Phase 2 trials, while maintaining a large accelerated filer status.

Key figure
Net loss $96.1M
4:01 PM ET Form 4
Insider Selling Mgic Investment Corp MTG

Mgic Investment President & COO Salvatore A. Miosi Sells $855K of Stock

Salvatore A. Miosi, President & COO, sold 30,000 shares of Mgic Investment Corp at $28.50 a share, worth $855K in total on Nov 2, 2026. Shares held after the trade: 410,951 (-6.8%).

Value
$855K
Shares
30,000
Price
$28.50
Role
President & COO
Holding change
-6.8%
Trade date
Nov 2, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.